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be used to monitor hemodialysis adequacy. However, since URE does not contribute
to the spectrometric signals, these data suggest the presence of undetermined
substances in spent dialysate with a removal profile similar to URE. Probably, β2M
removal cannot be monitored by spectrophotometric and spectrofluorimetric analysis
of spent dialysate, as indicated by the results found in LF dialysis.
Conclusions: In conclusion, urea into spent dialysate strictly correlates with
absorbance values, even if urea does not contribute to the spectrometric signals. A
predominant contribution to the spectrometric signals appears to be due to
substances to be identified, before validating spectrometric analyses in spent dialysate
as a method to monitor dialytic efficiency. In any case, spectrometric analysis of
spent dialysate cannot be used to monitor the plasma clearance of substances cleared
mainly by adsorption to dialysis membrane.
FP381 RELATIONSHIP OF KT/VM AND PROTEIN CATABOLIC RATE
WITH HYPERPHOSPHATEMIA IN PATIENTS UNDER
CHRONIC HEMODIALYSIS.
Edwin Marka-Castro1, Manuel Ignacio Torres Zamora2, Juan Giron-Mino3, Maria
Angelica Jaime-Solis1, Luis Mauro Arteaga1, Hector Romero1 and
Edwin Marka-Castro1
1Hospital Dalinde, 2Hospital Dalinde,Mexico D.F.Mexico, 3Hospital San Rafael
Introduction and Aims: Hyperphosphatemia is a frequent complication in patients
under chronic hemodialysis associated to high mortality. The purpose of this study
was to evaluate the relationship between hyperphosphatemia, dialysis dose (Kt/Vm),
and protein catabolic rate (nPCR) in adult patients under chronic hemodialysis
(three sessions per week).
Methods: 607 adult patients, 377 male and 240 female, 44.7±17.1 years old, were
studied. Patient had been more than three months in chronic hemodialysis, three
sessions per week. The patients were divided into two groups. Group 1 (316 patients)
with serum phosphorous(P) higher than 5.5 mg/dl and group (291 patients) with
serum phosphorous lower than 5.5 mg/dl . The mean values for the midweek
predialysis session of serum phosphorous, Kt/Vm, nPCR, and BUN predialysis are
shown in the following table. The statistical program SPSS 15 was used and a value
of p < 0.05 was considered significant.
Results: Results indicated that the value of Kt/Vm was higher in the patients that
had a serum phosphorous lower than 5.5 mg/dl. The protein catabolic rate (nPCR)
was higher in patients with serum phosphorous higher than 5.5 mg/dl. Finally, there
was a significant positive Pearson correlation between protein catabolic rate and
serum phosphorous (r=0.262. p<0.05).
Conclusions: It is concluded that hyperphosphatemia is associated with a reduction
of dialysis dose and with an increment of protein catabolic rate in patients under
chronic hemodialysis (three sessions per week).
FP382 NOVEL COMPOSITE DIALYSIS ADEQUACY INDEX:
COMPARISON WITH UREA STANDARD KT/V (STDKT/V)
Alp Akonur1, Ken Leypoldt1, Markku Asola1 and Bf Culleton2
1Baxter Healthcare Corporation, 2Baxter Healthcare, Deerfield, USA
Introduction and Aims: Although urea Kt/V has been used to define a dose of
dialysis because it is a measure of small solute clearance, it is increasingly recognized
that this parameter, by itself, is not sufficient for determining dialysis adequacy. For
haemodialysis (HD) prescriptions applied more frequently than thrice weekly, urea
stdKt/V has been proposed as a dialysis adequacy index; however, this index does not
account for differences in fluid retention or volume excess, a parameter associated
with patient mortality (Kalantar-Zadeh et al, Circulation 2009). Here, we propose a
novel composite dialysis adequacy index (ICDA) that combines a measure of small
solute clearance per treatment (weekly equilibrated urea Kt/V or eKt/V), treatment
frequency and volume excess.
Methods: A volume excess model was used to assess the effect of treatment
frequency and fluid intake as the time-averaged weekly volume excess (Vavg), similar
to that recently described by others (Stockinger et al, NDT 2011). Such a measure
can be expressed either for generic modalities as L of volume excess per L of fluid
intake or for specific modalities as L of volume excess. An underlying assumption of
our approach was that all patients achieved their target dry weight by the end of the
treatment. ICDA was formulated so that it was equivalent for generic thrice weekly
conventional HD (CHD) and generic peritoneal dialysis (PD) as ICDA = (eKt/
V÷eKt/V for CHD) ÷ (Vavg÷Vavg for CHD)½; ICDA is a measure of dialysis
adequacy relative to CHD.
Results: Calculated comparisons of ICDA and urea stdKt/V as adequacy indexes are
tabulated below for generic CHD, generic PD and short daily HD (SDHD) with the
NxStage System and for SDHD as delivered in the FHN Daily Trial (Chertow et al,
NEJM 2010):
Conclusions: ICDA provides a comparable measure of dialysis adequacy among
modalities as obtained when using stdKt/V; for example, ICDA for SDHD during the
FHN Daily Trial of 1.37 compares favorably with that when using stdKt/V (3.54/
2.49=1.41). The advantage of a composite dialysis adequacy index is that it can be
individualized for patient-specific differences in volume excess and can be readily
extended to include other parameters such as serum middle molecule and phosphous
concentrations.
FP383 KT/V IS A POOR PREDICTOR OF CONCENTRATION
OF A BROAD RANGE OF UREMIC TOXINS
Sunny Eloot1, Griet Glorieux2, Neirynck Nathalie3 and Raymond Vanholder4
1Hemodialysis 1p8, Ghent University Hospital, 2Ghent University Hospital, Ghent,
Belgium, 3Ghent University Hospital, Gent, Belgium, 4Ghent University Hospital -
Nephrology - Gent - Belgium
Introduction and Aims: Kt/V is used as marker of dialysis adequacy. The purpose
of this study was to investigate whether Kt/V is representative for the concentration
of a broad array of uremic toxins in patients on hemodialysis (HD).
Methods: Predialysis blood samples were taken during a midweek session in 75
chronic HD patients. Samples were analyzed by colorimetry, HPLC, or ELISA for a
broad range of uremic solutes: urea, creatinine (Crea), uric acid (UA), symmetric
dimethylarginine (SDMA), asymmetric dimethylarginine (ADMA),
beta-2-microglobulin (B2M), and free and total hippuric acid (HA),
3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF), indoxyl sulfate (IS),
indole acetic acid (IAA), p-cresylsulfate (PCS), and p-cresylglucuronide (PCG).
Associations were evaluated between concentrations and different parameters; i.e. age,
body weight (BW), Kt/V, Residual Renal Function (RRF), normalized Protein
Catabolic Rate (nPCR), and vintage. Multifactor analyses were performed per solute.
Results: Kt/V only showed non consistent correlations with concentrations of the
evaluated solutes; R negative for Crea and UA (both -0.2), and R positive for HA
and free HA (both 0.2) and ADMA (0.3), while correlations with the concentrations
of all other solutes were not significant. nPCR, on the contrary, showed the best
associations for the majority of solutes with R≈1 for urea, 0.4-0.6 for Crea, UA,
SDMA, PCS, and free PCS, and 0.2-0.4 for ADMA, HA, IS, PCG, free HA, and free
PCG. RRF showed inversed associations with B2M (R=-0.5) and with Crea, ADMA,
SDMA, HA, IS, PCG, free HA, free IS, free PCS, and free PCG (R=- 0.2 to -0.4). In
multifactorial analysis, nPCR and RRF but not Kt/V were significantly determining
the concentrations of ADMA, SDMA, HA, IS, PCG, free HA, free PCS, and free
PCG. Age, BW, and vintage did not contribute significantly to any correlation,
except for Crea. The percentage difference between highest and lowest absolute value
was in the same range for the parameters as for the concentrations, i.e. 60% (Kt/V)
to 100% (RRF), and 68% (ADMA) to 100% (total and free PCG), respectively.
Conclusions: In conclusion, uremic toxin concentration seems to be substantially
more dependent on dietary protein intake and residual renal function than on
dialysis adequacy as assessed by Kt/V. Hence, Kt/V cannot be considered as a major
representative for the evolution of the concentration of a large array of toxins in HD
patients, and by extension for their toxicity, which conceivably is
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